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OBJECTIVES We sought to evaluate: 1) the contribution of dendritic cells (DCs); and 2) the impact of
B-cell lymphoma 2 protein (Bcl-2), a central anti-apoptotic protooncogene, and of heat shock
protein 47 (HSP47), indicating subsequent collagen deposition, in neointima formation after
angioplasty.
BACKGROUND The origin of neointimal cells and the factors that promote their accumulation are still
unclear. Previous studies reported intimal presence of DCs and suggested cells of primarily
extravascular origin to contribute to arterial repair.
METHODS Sprague-Dawley rats underwent carotid balloon angioplasty. At different times after angio-
plasty, tissue sections were analyzed by immunohistochemistry using OX-62 and S100 as DC
markers and antibodies against Bcl-2 and HSP47, supplemented by electron microscopic
analysis of cell type and apoptosis.
RESULTS Four days after injury, DCs adhered along the internal elastic lamina and demonstrated
intense Bcl-2 and HSP47 expression, consistent with low apoptosis. With ongoing neointima
enlargement, luminal DCs remained prevalent and were colocalized with Bcl-2 and HSP47,
while signaling decreased to basal regions. Media showed no DCs and only low Bcl-2 and
HSP47 immunoreactivity. Adventitia transiently revealed a structural separation between day
4 and 7. Whereas the inner layer demonstrated sparse cellularity, apoptosis and no DC, Bcl-2,
and HSP47 labeling, the outer layer was characterized by high myofibroblast density with
strong Bcl-2 and HSP47 expression but absence of DCs.
CONCLUSIONS We identify DCs as novel components in early neointima formation, promoted by
coordinated anti-apoptotic Bcl-2 and HSP47 expression. Despite intense adventitial remod-
eling, there is no evidence of adventitial cell transmigration. (J Am Coll Cardiol 2003;42:
930–8) © 2003 by the American College of Cardiology Foundation
To abrogate restenosis and in-stent restenosis, future gen-
erations of drug-eluting stents may profit from a better
understanding of the pathogenic determinants leading to
intimal hyperplasia. Indeed, there is still a paucity of data
on: 1) the origin of neointimal cells; 2) the determinants
that allow these cells to survive in their environment; and 3)
the early events that contribute to neointima formation.
See page 939
Traditional concepts in vascular repair comprise prolifera-
tion, migration, and differentiation of smooth muscle cells
(SMCs) and other cells (1–4). Of note, recent work has
focused attention on circulating bone marrow-derived pro-
genitor cells as a source of neointimal cells that contribute to
restenosis, graft vasculopathy, and hyperlipidemia-induced
atherosclerosis, possibly differentiating to SMCs (5,6).
Likewise, bone marrow-derived endothelial and SMC pro-
genitor cells that share the surface marker CD34 were found
involved in arterial remodeling and neovascularization (7–10).
Most interestingly, dendritic cells (DCs) have also been
generated from myeloid CD34 progenitors (11,12), point-
ing to a common bone marrow origin with other blood-
borne precursors. So far, four stages of DC development
have been delineated: 1) bone marrow progenitors; 2)
circulating DC precursor cells; 3) tissue-residing immature
DCs; and 4) mature DCs as the most potent antigen-
presenting cells that prime “naive” T cells and initiate
specific immune responses (11). As to vascular pathology,
DCs were found in atherosclerotic plaques, apparently
involved in local immune-inflammatory reactions (13–15).
Also, a subendothelial network of DCs considered to be
part of the vascular-associated lymphoid tissue was detected
in the arteries of healthy young individuals at sites predis-
posed for late lesion formation (16,17). Vascular DCs in
arterial specimens were identified by S100, an intracellular
calcium-binding protein, and by typical ultrastructural fea-
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tures (14,15). Likewise in rats, the monoclonal OX-62
antibody that immuno-precipitates a molecule with -inte-
grin–like properties allowed for immunolabeling of bone
marrow-derived DCs (18).
Given the demand for a rapid controlled repair at the
injured vascular site, implicated cells should be protected to
survive in their local environment. Accordingly, recent
reports stressed the importance of a delicate balance be-
tween pro- and anti-apoptotic mediators of the B-cell
lymphoma 2 protein (Bcl-2) family for progression and
regression of vascular disease (19–21). The Bcl-2 protoon-
cogene encodes an intracellular membrane-associated pro-
tein that acts as an inhibitor of apoptosis in various cell types
including hematopoietic stem cells (22), DCs (23), and
vascular SMCs (19). Heat shock protein 47 (HSP47),
indicating subsequent collagen deposition essential for cell
anchorage and survival, is a 47 kDa intracellular glycopro-
tein from the serpin superfamily. Heat shock protein 47
transiently binds to newly synthesized procollagen and
dissociates from procollagen during its transport from the
endoplasmic reticulum to the cis-Golgi compartment (24).
Interestingly, HSP47 knockout mice displayed ruptured
blood vessels and abnormally orientated epithelium (24),
and HSP47 was found expressed in human fibrous atheroma
(25) and was low in coronary atherectomy specimens with
acute coronary syndromes compared with stable angina (26).
In the present series of experiments, we examined the
presence of neointimal DCs and the coordinated expression
of Bcl-2 and HSP47 as two important determinants for cell
survival and matrix formation after balloon angioplasty of
rat carotid arteries compared with non-injured controls.
These studies identified DCs as novel cellular components
involved in early neointima formation, while not supporting
transmigration of adventitial cells and, thereby, suggesting
circulating blood and/or the intima as the source of neoin-
timal cells.
METHODS
Rat carotid angioplasty. Male Sprague-Dawley rats (350
to 400 g) were anesthesized with an intraperitoneal injection
of ketamine (100 mg/kg, Parke-Davis Inc., Berlin, Ger-
many) and xylazine (15 mg/kg, Bayer Inc., Leverkusen,
Germany). Balloon angioplasty of the common carotid
artery was performed using a Fogarty 2F balloon embolec-
tomy catheter (Baxter Inc., Munich, Germany) as previously
described (1,3). The right carotid artery was surgically
exposed but not injured. At 0, 4, 24, and 48 h, 4, 7, 14, and
28 days after injury, 6 rats/time point were euthanized, and
both carotid arteries were excised. Animal investigation was
conform to the “Position of the American Heart Associa-
tion on Research Animal Use” adopted by the American
Heart Association November 11, 1984. Animal studies were
approved by the Committee for the Care and Use of
Animals of the Government of Oberbayern, Germany (AZ
211-2531).
Arteries were divided into two segments of equal size and
without additional manipulations, fixed in buffered 4%
formaldehyde for immunohistochemistry or in 3.5% glutar-
aldehyde for transmission electron microscopy (TEM). Of
note, the technique by which the artery was excised and
tissue preparation with avoidance of transluminal fixative
perfusion was regarded to be important in order to preserve
the innermost vascular wall layer.
Immunohistochemistry. Immunohistochemistry was per-
formed in 4 m paraffin-embedded arterial cross sections
after proteolysis with either 3% citrate (pH 6.0) or target
unmasking fluid (PanPath Inc., Amsterdam, the Nether-
lands). Non-specific antibody binding sites were blocked by
fetal calf serum at a dilution of 1:25 for OX-62, S100,
CD31, and HSP47, or by rabbit serum 1:20 for Bcl-2.
Sections were then treated with either the monoclonal
mouse anti-rat dendritic cell (1:20, Pharmingen Inc., Hei-
delberg, Germany, clone OX-62), mouse anti-rat CD31
(1:100, Biozol Inc., Eching, Germany, clone TLD-3A12),
or mouse anti-rat HSP47 antibodies (1:1,000, Calbiochem
Inc., Heidelberg, Germany, clone M16.10A1), or the poly-
clonal rabbit anti-S100 (1:100, Sigma Inc., Munich, Ger-
many, catalog number S2644), or rabbit anti-rat Bcl-2
antibodies (1:50, Pharmingen Inc., catalog number
13456E) for 12 h at 4°C. Selected sections were incubated
with monoclonal antibodies to -SM actin (1:75, Boehr-
inger Inc., Mannheim, Germany, clone asm-1) or stained by
Masson Goldner trichrome. For polyclonal antibodies, Af-
finiPure mouse anti-rabbit IgG (1:75, Dianova Inc., Ham-
burg, Germany, code-number 211-005-109) was applied for
30 min at room temperature after primary antibody incu-
bation. Primary antibodies bound to their target protein
were visualized with the APAAP technique (Boehringer)
and Fast Red (Sigma), and nuclei were counterstained with
hematoxylin.
Double staining experiments were performed with OX-
62/S100, OX-62/Bcl-2, and OX-62/HSP47. After OX-62
immunostaining with the APAAP method as described
above and Fast Blue (Sigma) as chromogen, tissue sections
were washed in phosphate-buffered saline (pH 7.3). Con-
secutively, sections were incubated with either S100, Bcl-2,
or HSP47 antibodies for 12 h at 4°C. For polyclonal S100
and Bcl-2, AffiniPure mouse anti-rabbit IgG was subse-
quently applied as described above. Bound S100, Bcl-2, or
HSP47 antibodies were visualized by APAAP and Fast
Abbreviations and Acronyms
Bcl-2  B-cell lymphoma 2 protein
CD34  hematopoietic stem cell marker
DC  dendritic cell
EC  endothelial cell
HSP47  heat shock protein 47
OX-62  dendritic cell marker
S100  dendritic cell marker
SMC  smooth muscle cell
TEM  transmission electron microscopy
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Red. To improve the detection of Fast Blue immuno-
staining, hemotoxylin nuclear staining was omitted. To
determine the OX-62 antibody specificity, rat spleen tissue
sections known to contain large amounts of DCs were taken
as positive controls. Additional positive controls used were
rat spleen and rat para-aortic lymph nodes for S100,
non-traumatized rat carotid arteries for CD31, rat thymus
for Bcl-2 and HSP47, and rat aortic segments for -SM
actin (not shown). Tissue sections without primary antibody
incubation served as negative controls in each staining
procedure, according to previous reports (14,15,17). To
exclude non-specific immunostaining, rat myocardial sec-
tions were used as negative controls and showed no immu-
noreactivity.
Histologic analysis. A computer-assisted morphometric
system (VFG-1-grafic card/VIBAM 0.0 Software) was used
to automatically count labeled nuclei per defined area
(20,27). Area, cellularity, and the percentage of OX-62-,
S100-, Bcl-2-, and HSP47-labeled cells were evaluated for
neointima, media, and adventitial layers from six randomly
selected fields per cross-section. The percentage of labeled
cells was expressed as the number of positive cells per total
number of cells for each layer (20).
Transmission electron microscopy. Transmission elec-
tron microscopy analysis of tissue segments was performed
according to standard protocols (20,27). Non-overlapping
images of randomly selected compartment regions were
photographically enlarged to a final magnification of
8,300. For each traumatized arterial segment, a total of 20
photographs (17  21 cm each) were taken, and 6 to 12
vascular cells were classified as SMCs, DCs, macrophages,
or lymphocytes. All together, recognition of 1,200 vascu-
lar cells was performed according to ultrastructural features.
Dendritic cells were identified by the presence of numerous
long dendritic processes and veils, lobed nuclei, profuse
mitochondria, and a prominent tubulovesicular system
(14,15). Smooth muscle cells, macrophages, and lympho-
cytes were classified according to ultrastructural features, as
previously reported in detail (27–30). The identification of
apoptotic cells was based upon specific morphological cri-
teria as defined in several reports (20,27,28).
Statistical analysis. All values are expressed as mean 
SEM. Statistical significance was evaluated with a two-
tailed unpaired Student t test for comparisons between the
means of two groups. Two-tailed bivariate correlations were
determined by the Pearson coefficient. The SPSS for Win-
dows software (version 10.0.7, SPSS Inc., Chicago, Illinois)
was used for statistic analysis. A value of p  0.05 was
interpreted to denote statistical significance.
RESULTS
Rat carotid arteries were analyzed 0, 4, 24, and 48 h, 4, 7,
14, and 28 days after balloon angioplasty. Transmural
response in regard to compartment area, cellularity, expres-
sion of OX-62, S100, Bcl-2, and HSP47, apoptosis, and cell
type was compared to non-injured arteries. Spatiotemporal
increase in neointimal and adventitial area as well as in
cellularity (Fig. 1) demonstrated the adequacy of the injury
model used to study specific mechanisms underlying neo-
intima formation and concomitant transmural remodeling.
Neointima. As early as day 4 after injury, single cells
adhered along the internal elastic lamina in a palisade-like
arrangement (Fig. 2A). A significant proportion of early
neointimal cells was identified as DCs due to strong
cell-bound OX-62 labeling (Fig. 2B), S100 immuno-
staining (Fig. 2C), and characteristic ultrastructural features
(Fig. 2D). In addition, TEM analysis proved low apoptosis
in the neointima at days 4 and 7 with 2% and 5%,
respectively (Fig. 2E). Gradually, intimal cells accumulated
to circumferential uniform layers (Figs. 2F to 2H) expand-
ing to a neointimal territory with high cellularity (Fig. 1).
At seven days after injury, immunoreaction for DCs
was maximal (45  14%), and significantly decreased at
later time points (Fig. 3A). Rat spleen sections taken as
positive controls consistently demonstrated intense OX-62
Figure 1. Bar graph demonstrating mean area (A) and cellularity (B) of
each vascular compartment during time course. Open bars  neointima;
hatched bars  media; solid bars  adventitia. *p  0.05 vs. baseline, as
indicated. Of note, medial cellularity decreased by 29% (‡p  0.002) at
48 h compared with baseline and recovered (p  0.001) at day 4 (not
marked). Uninjured control segments (C) did not show neointima forma-
tion or altered structure of media and adventitia.
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immunoreactivity (Fig. 3B). Neither endothelial cells nor
macrophages and only a few lymphocytes (2%) were
detected in the neointima at this time and later, when most
of the neointimal cells were positive of -smooth muscle
actin (Figs. 2G and 2H). In 28-day injured arteries, DCs
were found exclusively at the luminal surface, while most of
Figure 2. Photomicrographs of early neointima formation, focused on the luminal surface region. (A) Palisade-like alignment of single cells (arrows) along
the internal elastic lamina (IEL) at day 4 (trichrome staining). (B) Strong cell-bound OX-62 signaling restricted to early neointima contrasts to unlabeled
media at day 7. (C) Magnified detail of neointima at day 7 demonstrating consistent colocalization of OX-62 (dark blue) and S100 (red) in neointimal
dendritic cells (DC) (no nuclear counterstaining). (D) Transmission electron microscopy identification of two DCs extending along the IEL at day 7. Note
their long dendritic processes and veils, the lobed nucleus, and prominent tubulovesicular network. (E) Transmission electron microscopy detection of
apoptosis located in basal neointima close to IEL. Apoptotic shrinkage and detached anchorage from surrounding extracellular matrix are indicated by
condensed cytoplasm and pericellular region markedly less dense than adjacent matrix. (F) Representative hyperplastic neointima at day 28. Note the distinct
residual OX-62 labeling along the luminal surface, while the vast majority of cells located in basal regions are negative. (G) Transmission electron
microscopy image of representative hyperplastic neointima at day 28 that predominantly comprises cells with SMC appearance and apparently shows no
apoptosis. Luminal neointima reveals perpendicular alignment of the cells and loose extracellular matrix compared with basal regions. (H) Intense -smooth
muscle actin immunoreactivity of the neointima and weak staining of medial SMCs at day 28. Bar  30 m (A to C, F to H); bar  5 m (D, E).
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the structured neointima contained cells with SMC appear-
ance, and apoptosis was 1% (Fig. 2G).
Neointimal cells showed strongly cell-bound signals of
the anti-apoptotic Bcl-2 protooncogene by day 4 (Fig. 4A).
Later, at days 14 and 28, Bcl-2-stained cells were predom-
inantly localized close to the luminal surface, and gradually
decreased to basal neointima (Figs. 4B and 4C). Double
immunostaining demonstrated OX-62 DCs to have high
Bcl-2 expression (Fig. 4C). Quantified expression of Bcl-2
in neointima with time is outlined in Figure 5A. In serial
sections HSP47, indicating subsequent collagen deposition,
demonstrated a similar postangioplasty expression pattern as
Bcl-2 (Figs. 4D to 4F, and 5B). There was coexpression of
OX-62 and HSP47 at the luminal surface that disappeared
to deeper neointimal areas (Fig. 4F). Throughout the time
course of neointima formation, a positive relationship was
seen between the expression of HSP47 and that of Bcl-2
(r  0.49, p  0.04). At day 28 a strong positive correlation
between HSP47 expression and neointimal area was found
(r  0.86, p  0.03). In contrast, luminal non-traumatized
control segments consistently revealed no signals of either
OX-62, S100, Bcl-2, or HSP47.
Media. The time course of medial area and cellularity after
angioplasty was remarkably constant between 4 and 28 days
(Fig. 1). No DCs were detected at any time point. Specific
signals of Bcl-2 were first seen at 48 h after angioplasty and
were maximal (9%) at day 14 beyond an overall low
expression, whereas HSP47 immunoreactivity was constant
(5%) within a constitutive expression profile (Fig. 5).
Adventitia. Adventitial remodeling, indicated by a signif-
icant increase in compartment area and cellularity, was
present as early as days 4 and 7 (Fig. 1). During this period,
a transient structural separation of the adventitia occurred
resulting in an inner hypocellular and an outer hypercellular
layer with strong -SM actin signaling and intense neovas-
cularization (Fig. 6A). Ultrastructurally, the inner zone
contained several apoptotic cells and large areas of non-
organized extracellular matrix, while the outer zone com-
prised numerous viable fibroblast-like cells embedded in
structured collagen matrix and several microvessels (Figs. 6B
and 6C). Adventitial cells demonstrated no immuno-
reactivity indicating presence of DCs, whereas neointimal
cells displayed intense labeling (Fig. 6D). Adventitial cells
located in the outer zone showed strong signaling of both
Bcl-2 and HSP47 with maximal expression of 29% and
57%, respectively (Figs. 5, 6E and 6F). At no time point
studied were signals of either OX-62, S100, Bcl-2, and
HSP47 detected in the inner hypocellular zone of the
adventitia.
DISCUSSION
DCs in early neointima formation. As the central finding,
our data consistently demonstrate the early apposition of
DCs along the injured artery, maximal DC frequency
between days 4 and 7, and distinct luminal preservation up
to day 28, when expression decreased (Figs. 2 and 3). The
presence of DCs in the context with postangioplasty neo-
intima formation is new and intriguing, and adds another
facet to previous, traditional, as well as novel concepts
concerning the origin and nature of neointimal cells (1–
6,31). So far, DCs were detected in human carotid plaques
(14) and aortic lesions of hypercholesterolemic rats (15),
suggesting local immune-inflammatory reactions. Another
report on autopsy arteries from young adults supported a
role of vascular DCs as a nidus of subsequent lesion
formation (17), and, most recently, activated DCs were
shown to contribute to the progression of atherosclerosis
(32).
Our findings of OX-62S100 DCs and absence of
macrophages and endothelial cells (ECs) in incipient neo-
intima as early as day 4 point to a definite time, when
homing of DCs begins. It is known that inflammatory cells
are present along the luminal surface of the injured artery
from 2 h to three days. Among these cells, neutrophils and
macrophages express messenger RNAs encoding cell adhe-
Figure 3. Dendritic cells in early neointima formation. (A) Bar graph
demonstrating percentage of neointimal OX-62 dendritic cells (DC) after
angioplasty. Open bars  neointima. *p  0.05 versus value at seven days.
(B) Staining of DCs in rat spleen as positive control for OX-62. Bar  30
m (B).
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sion molecules and chemokines (33). In consequence, these
factors could very well induce recruitment and homing of
DCs (11). Our present data show the onset of neointima
formation at days 4 and 7, parallel to the profile of DC
marker expression that is maximal within the same time
window (Fig. 3A), while advanced neointima was predom-
inantly composed of -smooth muscle actin SMCs (Figs.
2G and 2H). Likewise, Sata et al. (5) reported that bone
marrow-derived neointimal cells in mice were negative for
markers of SMCs and ECs, when they attached to the
Figure 4. Photomicrographs of specific B-cell lymphoma 2 protein (Bcl-2) (A to C) and heat shock protein 47 (HSP47) immuno-staining (D to F) in
neointima formation from day 4 to day 28 after injury. (A) Strongly cell-bound signaling of Bcl-2 in incipient neointima formation at day 4 (arrow). (B)
Luminal prevalence of Bcl-2-positive cells and declining expression in basal regions at day 14. (C) Double staining for OX-62 (dark blue) and Bcl-2 (red)
in neointima at day 28 demonstrating persistent luminal prevalence of Bcl-2 dendritic cells (no nuclear counterstaining). (D) Luminal cells adhering to
the internal elastic lamina exhibit strong HSP47 labeling at day 4. (E) Heat shock protein 47 signals are maximal at the luminal surface and continuously
decrease to basal regions at day 28. (F) Double staining for OX-62 (dark blue) and HSP47 (red) in neointima at day 14. Note dendritic cell-bound
neointimal HSP47 expression at the luminal border and sparse HSP47 immunoreactivity without presence of dendritic cells in deep neointimal areas (no
nuclear counterstaining). Bar  30 m (A to F).
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luminal site of the artery 7 days after injury. Later, the
dilated lumen gradually narrowed due to neointimal hyper-
plasia primarily composed of SMCs (5). Also, Christen et
al. (4) showed percentages of -smooth muscle actin
neointimal cells that increased from 26% at day 7 to 98% at
day 30 in injured porcine coronary arteries. Disappearance
of DC markers and presence of SMC features could mean
that a proportion of DCs migrate out of the neointima or
that DC apposition decreases with time after injury. Other
possibilities may be transdifferentiation into SMCs as re-
cently shown for hematopoietic stem cells (5) or neointimal
cell death, although the latter is not supported by our
present data that consistently demonstrate low neointimal
apoptosis between days 4 and 28.
Coordinated Bcl-2 and HSP47 expression in DCs and
neointimal cell accumulation. Parallel to incipient lesion
formation, we observed a strong Bcl-2 labeling of neointi-
mal cells. Although expression of Bcl-2 decreased later like
those of OX-62 and S100, the luminal prevalence of Bcl-2
DCs persisted (Figs. 2F, 4B, 4C, and 5A); Bcl-2 is known
to mediate DC longevity (23); decreased Bcl-2 expression
reduced the viability of CD34-derived DCs in vitro (34).
Also, cultured aortic SMCs were found to be resistant to
apoptosis after transfection by a retroviral vector for Bcl-2
(19). Consistent with apoptosis data in a postangioplasty
rabbit model (35), our TEM findings demonstrate neointi-
mal apoptosis as low as 2% and 5% at days 4 and 7, which
is the peak of Bcl-2 expression. A low 3% level of apoptosis
was also found in hyperplastic human restenosis (20). Taken
together, our present data support the concept of an upregu-
lated anti-apoptotic Bcl-2 expression of luminally adherent
DCs and adjacent cells in basal neointima to preserve cellular
integrity until neointimal tissue consolidation occurs.
Heat shock protein 47 was expressed in neointima re-
markably similar to the expression profile of Bcl-2 and was
clearly colocalized with DC markers in luminally adherent
cells (Figs. 4F and 5B). Heat shock protein 47 triggers
collagen synthesis and matrix deposition that allow cellular
anchorage and antagonize a special form of apoptosis called
anoikis (36), thereby again supporting neointimal cells to
survive. Indeed, in view of low apoptosis, the present study
shows positive relationships between Bcl-2 and HSP47 and
between HSP47 and neointimal area at day 28. These
findings may strengthen the concept of coordinated anti-
apoptotic signals that promote neointima formation, in
concert with additional determinants, that is, the protoon-
cogene Bcl-xL and the neomatrix constituent tenascin,
which were recently shown to be involved in neointima
formation (3,21).
No evidence for transmigration of adventitial cells. Our
quantitative, compartment-specific data do not show signif-
icant changes in medial cellularity reflecting transmigration
of cells from adventitia to neointima between days 4 and 28
after angioplasty, while formation of hyperplastic neointima
and hypercellular adventitial remodeling occur (Fig. 1). In
addition, Bcl-2 signaling in the media was sparse, and
constitutive HSP47 expression remained unchanged (Fig.
5B). If it is true that Bcl-2 and HSP47 act as survival factors
for neointimal and adventitial cells, medial expression
should be increased in case of transmural migration. Also,
the inner adventitial layer was characterized by sparse
cellularity (Fig. 6). Particularly in this corridor, we detected
neither HSP47 nor Bcl-2 signaling, although parallel ex-
pression of both determinants was maximal in the outer
adventitia and the innermost neointima (Figs. 5 and 6).
Likewise, in traumatized rat carotid arteries whose adven-
titial cells were subsequently treated with PKH26 fluorescin
stain, no labeled cells were detected in the media at days
3 and 5 or in the neointima at day 14 (31). Taken to-
gether, these data in rats do not give evidence for trans-
mural migration of adventitial cells, and indirectly support
intimal and/or circulating progenitor cells as source of
neointima.
Of note, data from an animal restenosis model can-
not directly be extrapolated to the clinical scenario in
patients. Among several drawbacks, the factors mediat-
ing the vascular response to injury in humans are not
identical to those in rodents. Animal models usually lack
the high-grade preexisting atherosclerotic lesions with its
complex architecture. Also, it should be noted that quan-
Figure 5. Bar graph demonstrating mean expression of B-cell lymphoma 2
protein (Bcl-2) (A) and of heat shock protein 47 (HSP47) (B) in each
vascular compartment during time course. Open bars  neointima;
hatched bars  media; solid bars  adventitia. *p  0.05 versus value at
four days, as indicated for neointima; ‡p  0.05 versus baseline, as
indicated for adventitia.
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titative immunohistochemistry is a technique fraught
with potential artifactual influences including sampling
error, section thickness, staining variability, dilutions, and
blocking, etc. Whenever possible, these limitations were over-
come by a large number of analyzed probes and controls within
animal experimentation and tissue staining procedures.
Figure 6. Photomicrographs of transmural response to injury, focused on adventitial remodeling. (A) Intense -smooth muscle actin immunoreactivity in
the media and outer adventitia at day 4; also perivascular microvessels of the vasa vasorum are positive (arrows). (B) Transmission electron microscopy detail
of hypocellular inner adventitia at day 7 illustrating two cells that simultaneously display end-stage apoptotic shrinkage (arrows); see large regions of
non-structured matrix (*). (C) Transmission electron microscopy detail of hypercellular outer adventitia at day 7 showing several viable cells with
fibroblast-like appearance embedded in dense extracellular matrix. Also, see in the endothelial cell lining a perivascular capillary (*). (D) No signals of
OX-62 dendritic cells are found in the media (M) and the broad adventitia at day 4, in contrast to intense OX-62 immuno-staining along the luminal
surface. (E) Cell-bound B-cell lymphoma 2 protein signals are exclusively found in the outer adventitia (arrows) at day 4. While demarcation from
perivascular connective tissue is not always possible, inner adventitia (*), M, and lumen (L) can be easily distinguished. (F) Transmural heat shock protein
47 expression pattern at day 4. Note the distinct immuno-staining exclusively located in the outer adventitia. Bar 50 m (A, D to F); bar 5 m (B, C).
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Taken together, in perspective to potential clinical impli-
cations, the present data of neointimal Bcl-2HSP47 DC
accumulation highlight these determinants as potential
candidates for a specific local modulation at the injured
vasculature, for example, by drug-eluting stents. In partic-
ular, DCs, which exclusively populate the neointimal site,
seem to be attractive as carriers for targeted therapies such as
DC-mediated gene transfer.
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